Literature DB >> 9443704

Selective serotonin reuptake inhibitors: infrequent medical adverse effects.

R J Goldberg1.   

Abstract

The selective serotonin reuptake inhibitors have a very favorable safety profile. However, because of the wide use of this drug group, even low-frequency adverse effects become more prevalent. This article reviews 5 of these relatively infrequent adverse medical effects associated with the use of selective serotonin reuptake inhibitors: the syndrome of inappropriate antidiuretic hormone secretion, extrapyramidal effects, bleeding complications, cardiac arrhythmias, and the serotonin syndrome.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9443704     DOI: 10.1001/archfami.7.1.78

Source DB:  PubMed          Journal:  Arch Fam Med        ISSN: 1063-3987


  11 in total

Review 1.  Role of pharmacogenomics in individualising treatment with SSRIs.

Authors:  Dalu Mancama; Robert W Kerwin
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 2.  Serotonin syndrome: a brief review.

Authors:  Philippe Birmes; Dominique Coppin; Laurent Schmitt; Dominique Lauque
Journal:  CMAJ       Date:  2003-05-27       Impact factor: 8.262

3.  Discovery of novel selective serotonin reuptake inhibitors through development of a protein-based pharmacophore.

Authors:  Sankar Manepalli; Laura M Geffert; Christopher K Surratt; Jeffry D Madura
Journal:  J Chem Inf Model       Date:  2011-09-02       Impact factor: 4.956

4.  Up-regulation of 5-HT2 receptors is involved in the increased H-reflex amplitude after contusive spinal cord injury.

Authors:  Jae K Lee; Christopher S Johnson; Jean R Wrathall
Journal:  Exp Neurol       Date:  2006-10-23       Impact factor: 5.330

5.  Selective serotonin reuptake inhibitors: measurement of effect on platelet function.

Authors:  Donna Jo McCloskey; Teodor T Postolache; Bernard J Vittone; Khanh L Nghiem; Jude L Monsale; Robert A Wesley; Margaret E Rick
Journal:  Transl Res       Date:  2007-11-20       Impact factor: 7.012

6.  Depression treatment in patients with coronary artery disease: a systematic review.

Authors:  Gita Ramamurthy; Edgardo Trejo; Stephen V Faraone
Journal:  Prim Care Companion CNS Disord       Date:  2013-10-24

Review 7.  SSRIs and upper gastrointestinal bleeding: what is known and how should it influence prescribing?

Authors:  Susanne O Dalton; Henrik T Sørensen; Christoffer Johansen
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 8.  Cardiovascular considerations in antidepressant therapy: an evidence-based review.

Authors:  Habibeh Yekehtaz; Mehdi Farokhnia; Shahin Akhondzadeh
Journal:  J Tehran Heart Cent       Date:  2013-10-28

9.  Observational study of upper gastrointestinal tract bleeding events in patients taking duloxetine and nonsteroidal anti-inflammatory drugs: a case-control analysis.

Authors:  Hu Li; Yingkai Cheng; Jonna Ahl; Vladimir Skljarevski
Journal:  Drug Healthc Patient Saf       Date:  2014-10-29

10.  The risk of bleeding with duloxetine treatment in patients who use nonsteroidal anti-inflammatory drugs (NSAIDs): analysis of placebo-controlled trials and post-marketing adverse event reports.

Authors:  David G Perahia; Mark E Bangs; Qi Zhang; Yingkai Cheng; Jonna Ahl; Elijah P Frakes; Michael J Adams; James M Martinez
Journal:  Drug Healthc Patient Saf       Date:  2013-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.